Table 3.
Adverse events reported in this study
| Telbivudine | Control | P value | |
|---|---|---|---|
| CK Elevation of mother, n (%) | 7 (5%) | 0 (0%) | 0.022 |
| Malformation induced labor, n | 1 | 1 | 1.000 |
| Abortion, n | 1 | 2 | 0.575 |
| Premature labor, n | 3 | 2 | 1.000 |
| Congenital diseases, n | 1 | 1 | 1.000 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.